Allogeneic tumor lysate-pulsed autologous dendritic cell (Institut d'Investigacions Biomediques August Pi I Sunyer)

N/A

Report date: 2022/12/31 17:29:51

Base Information

Drug NameAllogeneic tumor lysate-pulsed autologous dendritic cell (Institut d'Investigacions Biomediques August Pi I Sunyer)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdibaps - Institut D'Investigacions Biomèdiques August Pi I Sunyer
China Registration ClassN/A

Develop Information

Active CompaniesIdibaps - Institut D'Investigacions Biomèdiques August Pi I Sunyer
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A